Investing.com - Vigil Neuroscience reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations.
Vigil Neuroscience announced earnings per share of $-0.53 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.62 on revenue of $0.00.
Vigil Neuroscience shares are down 4.96% from the beginning of the year, still down 48.66% from its 52 week high of $18.27 set on February 17.
Vigil Neuroscience shares lost 23.86% in intra-day trade following the report.
Vigil Neuroscience follows other major Healthcare sector earnings this month
Vigil Neuroscience's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar